生物标志物 生物标志物
Anto Praveen Rajkumar Rajamani1,2, Fatma Busra Isik3, Helen Miranda Knight4
1University of Nottingham, Nottingham, Nottinghamshire, United Kingdom.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
研究人员开发了一种新的血液检测方法,使用血小细胞外囊泡 (SEV) RNA 来区分患有勒维体痴呆症 (DLB) 和阿尔茨海默病 (AD). 这种以神经炎症为重点的测试显示了准确的DLB诊断的前景.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 分子生物学分子生物学
背景情况:
- 从阿尔茨海默氏病 (AD) 区分患有勒维体痴呆症 (DLB) 是非常重要的,因为不同的预后,风险因素和治疗方法.
- 目前用于DLB的基于放射性同位素的成像生物标志物并不广泛使用,这凸显了需要基于血液的诊断标志物.
- 慢性微质激活与阿尔茨海默病理有关,但不在DLB中,这表明微质衍生生物标志物可能有助于差异化.
研究的目的:
- 识别和验证基于血液的生物标志物,以准确区分DLB和AD.
- 研究血小细胞外囊泡 (SEV) RNA,特别是微质衍生RNA,作为DLB的诊断标记物的实用性.
- 改进一个原型的多重RNA试验,以提高诊断准确度.
主要方法:
- 从患有DLB,AD和对照个体 (N=30) 收集了血样本.
- 从血中分离出小细胞外囊泡 (SEVs),并使用TMEM119免疫沉来丰富微质起源.
- 从丰富的SEV中提取RNA,并使用下一代RNA测序分析差异性基因表达.
主要成果:
- 建立了一种用于丰富微质源血SEVs的新方案,使得低输入RNA的测量成为可能.
- 下一代RNA测序确定了与AD患者相比,DLB患者的28种差异表达RNA,包括MAPK6,IRAK1和MIR28.
- 功能性丰富分析显示了与DLB的Galactosyltransferase活性和炎症相关的通路的下调.
结论:
- 血SEVRNA专注于神经炎症标志物,可以准确地区分DLB和AD.
- 已识别的差异表达RNA将用于开发多重血SEVRNA试验.
- 开发的试验的诊断准确性将在一个独立的队列中进行评估.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516